Article Versions Notes

Boussios S, Karathanasi A, Cooke D, Neille C, Sadauskaite A, Moschetta M, Zakynthinakis-Kyriakou N, Pavlidis N. PARP Inhibitors in Ovarian Cancer: The Route to “Ithaca”. Diagnostics. 2019; 9(2):55. https://doi.org/10.3390/diagnostics9020055

Boussios, Stergios, Afroditi Karathanasi, Deirdre Cooke, Cherie Neille, Agne Sadauskaite, Michele Moschetta, Nikolaos Zakynthinakis-Kyriakou, and Nicholas Pavlidis. 2019. "PARP Inhibitors in Ovarian Cancer: The Route to “Ithaca”" Diagnostics 9, no. 2: 55. https://doi.org/10.3390/diagnostics9020055

Boussios, S., Karathanasi, A., Cooke, D., Neille, C., Sadauskaite, A., Moschetta, M., Zakynthinakis-Kyriakou, N., & Pavlidis, N. (2019). PARP Inhibitors in Ovarian Cancer: The Route to “Ithaca”. Diagnostics, 9(2), 55. https://doi.org/10.3390/diagnostics9020055